Biomerieux 

€91.3
0
+€1.55+1.73% Today

Statistics

Day High
91.3
Day Low
91.3
52W High
130.7
52W Low
89.4
Volume
0
Avg. Volume
1
Mkt Cap
0
P/E Ratio
-
Dividend Yield
-
Dividend
-

Upcoming

Earnings

27FebExpected
Q4 2025
2.12
2.45
2.78
3.12
Expected EPS
2.11719404169
Actual EPS
N/A

People Also Follow

This list is based on the watchlists of people on Stock Events who follow EYWN.MU. It's not an investment recommendation.

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Thermo Fisher Scientific
TMO
Mkt Cap184.37B
Thermo Fisher Scientific offers a broad range of analytical instruments and reagents, directly competing in the diagnostics and research sectors similar to Biomerieux.
Danaher
DHR
Mkt Cap134.19B
Danaher Corporation, through its subsidiaries like Cepheid, competes in the life sciences and diagnostics market, offering products that overlap with Biomerieux's offerings.
Bio-Rad Laboratories
BIO
Mkt Cap7.54B
Bio-Rad Laboratories provides a variety of products for the life science research and clinical diagnostics markets, making it a direct competitor in several areas of Biomerieux's business.
Resmed
RMD
Mkt Cap33.41B
ResMed Inc. is known for its products in the health sector, including diagnostics, where it competes with Biomerieux in certain niches.
Becton Dickinson
BDX
Mkt Cap55.87B
Becton, Dickinson and Company operates in the healthcare and diagnostics industries, offering products and services that compete with Biomerieux's diagnostics solutions.
Hologic
HOLX
Mkt Cap16.97B
Hologic, Inc. specializes in diagnostics and medical imaging systems, directly competing with Biomerieux in the diagnostics market.
Qiagen NV
QGEN
Mkt Cap8.43B
Qiagen N.V. offers technologies and products for preanalytical sample preparation and diagnostics, competing in the molecular diagnostics market alongside Biomerieux.
Abbott Laboratories
ABT
Mkt Cap174.29B
Abbott Laboratories has a broad range of healthcare products including diagnostics, competing with Biomerieux especially in the areas of infectious disease testing.
Agilent Technologies
A
Mkt Cap32.54B
Agilent Technologies provides analytical instruments, services, and consumables in the life sciences, diagnostics, and applied chemical markets, competing with Biomerieux in laboratory diagnostics.
Guardant Health
GH
Mkt Cap10.31B
Guardant Health operates in the precision oncology field, offering liquid biopsy tests that compete with Biomerieux's molecular diagnostics solutions in the oncology segment.

About

bioMérieux S.A. develops and produces in vitro diagnostic solutions for the diagnosis of infectious diseases in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. The company offers systems, which use biological samples to diagnose infectious diseases, cardiovascular pathologies, and various cancers; and microbiological testing of manufacturing primarily for food, pharmaceutical, cosmetics, and veterinary sectors. It serves clinical and hospital laboratories, physicians, blood banks, and industrial control laboratories. The company was formerly known as B-D Mérieux. bioMérieux S.A. was founded in 1963 and is headquartered in Marcy l'Etoile, France. bioMérieux S.A. is a subsidiary of Institut Mérieux SA.
Show more...
CEO
Mr. Pierre Boulud
Employees
14147
Country
France
ISIN
FR0013280286

Listings

0 Comments

Share your thoughts

FAQ

What is Biomerieux stock price today?
The current price of EYWN.MU is €91.3 EUR — it has increased by +1.73% in the past 24 hours. Watch Biomerieux stock price performance more closely on the chart.
What is Biomerieux stock ticker?
Depending on the exchange, the stock ticker may vary. For instance, on exchange Biomerieux stocks are traded under the ticker EYWN.MU.
Is Biomerieux stock price growing?
EYWN.MU stock has fallen by -4.3% compared to the previous week, the month change is a -2.92% fall, over the last year Biomerieux has showed a -20.54% decrease.
When is the next Biomerieux earnings date?
Biomerieux is going to release the next earnings report on July 28, 2026.
How many employees does Biomerieux have?
As of April 15, 2026, the company has 14,147 employees.
In which sector is Biomerieux located?
Biomerieux operates in the Other sector.
When did Biomerieux complete a stock split?
Biomerieux has not had any recent stock splits.
Where is Biomerieux headquartered?
Biomerieux is headquartered in Marcy-l'Étoile, France.